Medtronic's Heart Catheter Achieves Safety And Efficacy Goals In Patients With Irregular Heartbeat
On Friday, Medtronic plc (NYSE:MDT) released results from the SPHERE Per-AF study comparing Sphere-9 to the conventional Thermocool SmartTouch SF radiofrequency ablation catheter with the Carto 3 Syst
Medtronic (MDT) Reports Favorable SPHERE Per-AF Trial Outcome
Unlocking Q4 Potential of Medtronic (MDT): Exploring Wall Street Estimates for Key Metrics
EuroPCR: Medtronic Evolut TAVR Platform Demonstrates Improved Quality of Life for Women With Severe Aortic Stenosis
Assessing Medtronic's Market Position in the Evolving Electrophysiology Landscape
Wells Fargo Sticks to Their Buy Rating for Medtronic (MDT)
Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Medtronic (MDT – Research Report) yesterday and set a price target of $102.00. The company’s shares closed last Friday at $85.92.
Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved when a business collapses.
Weekend Readings | Buffett's “mysterious” holdings are in Chubb Insurance, losing Munger's Daily Journal and starting to cut back...
This article analyzes 10 “investment giants” including Berkshire Hathaway, The Daily Journal, Gao Lin HLR, Jing Lin, Qiaoshui, Baillie Gifford, ARK, Fisher Price, and Pershing Plaza.
Medtronic Study of Affera Sphere-9 Catheter Meets Endpoints
Medtronic Trial for AFib System Achieves Endpoints
Medtronic said its combined system for use during treatment of atrial fibrillation reached its safety and efficacy endpoints in a trial.
Medtronic Stock Trades up for the Seventh Straight Session
Medtronic Data Shows Safety and Efficacy of Affera, Sphere-9 All-in-one Ablation
Medtronic Unusual Options Activity
Financial giants have made a conspicuous bullish move on Medtronic. Our analysis of options history for Medtronic (NYSE:MDT) revealed 23 unusual trades.
Medtronic's Investigational Defibrillation Lead Meets Primary Study Endpoints
Investors Heavily Search Medtronic PLC (MDT): Here Is What You Need to Know
Late-breaking Data Show Reliable Performance of Small-diameter Defibrillation Lead, the Medtronic OmniaSecure
Global LEADR clinical trial meets safety and effectiveness objectives; results presented at Heart Rhythm 2024 and simultaneously published in Heart RhythmDUBLIN and BOSTON, May 17, 2024 /PRNewswire(op
Medtronic Affera Mapping and Ablation System With Sphere-9 Catheter Achieves Endpoints for Safety and Efficacy, Providing Promising Evidence for the Future of Atrial Fibrillation Treatment
HRS late breaking data: SPHERE Per-AF trial demonstrates novel all-in-one system delivers exceptional results, plus increased efficiency and improved quality of lifeDUBLIN and BOSTON, May 17, 2024 /PR
Medtronic (MDT) Gets a Buy From Barclays
Warren Buffett's Unique Formula To Success Unveiled By Harvard Expert: 'You Can't Just Correct Your Weaknesses'
Warren Buffett's enduring success secret has been revealed by a Harvard University expert, offering a unique insight into the legendary investor's approach.What Happened: Bill George, a leadership exp
Bridgewater's Top Q1 Buys, Sells: Amazon, AMD, Medtronic, CME, Others
No Data